1. 1) Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int., 66, 920–923 (2004).
2. 2) Liu Z-H. Nephrology in china. Nat. Rev. Nephrol., 9, 523–528 (2013).
3. 3) Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M, Alberta Kidney Disease Network. Relation between kidney function, proteinuria, and adverse outcomes. JAMA, 303, 423–429 (2010).
4. 4) Floege J, Feehally J. Treatment of IgA nephropathy and Henoch-Schonlein nephritis. Nat. Rev. Nephrol., 9, 320–327 (2013).
5. 5) Lv Q-W, Zhang W, Shi Q, Zheng W-J, Li X, Chen H, Wu Q, Jiang W-L, Li H-B, Gong L, Wei W, Liu H, Liu A, Jin H-T, Wang J-X, Liu X-M, Li Z-B, Liu B, Shen M, Wang Q, Wu X-N, Liang D, Yin Y-F, Fei Y-Y, Su J-M, Zhao L-D, Jiang Y, Li J, Tang FL, Zhang FC, Lipsky PE, Zhang X. Comparison of Tripterygium wilfordii HOOK F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann. Rheum. Dis., 74, 1078–1086 (2015).